From 2017 to 2022, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) more than doubled, according to a study published online July 17 in the Jour ...

For patients with peripheral artery disease (PAD) and type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with lower rates of mortality, hospitalization, ...

Real-world data indicate that pegcetacoplan treatment for GA may help patients avoid rapid and catastrophic visual acuity ...

IOP elevation following implantation with a dexamethasone intravitreal device is more severe for patients with particular ...

The 2025-2026 SARS-CoV-2 vaccines provided protection against ER and urgent care visits among individuals with COVID-19-like illness.

Women with a history of migraine who are postmenopausal may face a modestly increased risk for ischemic stroke.